Maximizing Treatment Outcomes for MDS in the Transplant Patient

These lectures were originally presented as part of a satellite symposium at the 2008 BMT Tandem Meetings  in San Diego, CA on February 13, 2008.

This multimedia activity will use a combination of expert presentations of clinical data in conjunction with patient case reports to establish the role of transplantation and drug therapy in treating patients with myelodysplastic syndromes (MDS). World renowned thought leaders will discuss patient case scenarios and data supporting various treatment strategies for MDS, including pharmacologic manipulation, with the goal of defining ways to maximize treatment outcomes in the transplant patient. This program is intended for transplantation and hematology specialists.

	Current Issues in Stem Cell Transplantation for MDS Bart L. Scott, MD, Program Chair Medical Oncologist Seattle Cancer Care Alliance Research Associate in the Clinical Research Division Fred Hutchinson Cancer Research Center Seattle, Washington View Presentation
	Pre-transplant Therapy of MDS Madan H. Jagasia, MBBS, MS Director, Out Patient Transplant Program Assistant Professor Division of Hematology & Oncology Vanderbilt-Ingram Cancer Center Nashville, Tennessee View Presentation
	Preventing Relapse: Enhancing GVL through Pharmacologic Manipulation Marcos J. de Lima, MD Associate Professor of Medicine Department of Stem Cell Transplantation and Cellular Therapy University of Texas M.D. Anderson Cancer Center Houston, Texas View Presentation
	Download the program handout (PDF)